HLA-A*0301 & B2M & KRASG12V (VVGAVGVGK) Produktliste
You Have Viewed 0 Of 0 Results
Klinische Arzneimittelinformation
| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| DNDI-6148 | DNDI-6148 | Phase 1 Clinical | Drugs For Neglected Diseases Initiative | Infections; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral | Details |
| AN-3661 | AN-6426; AN-3661 | Phase 1 Clinical | Anacor Pharmaceuticals Inc | Malaria | Details |